Image_2_Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.tiff
Despite the global interest and the unprecedented number of scientific studies triggered by the COVID-19 pandemic, few data are available from developing and low-income countries. In these regions, communities live under the threat of various transmissible diseases aside from COVID-19, including malaria. This study aims to determine the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroreactivity of antibodies from COVID-19 and pre-COVID-19 samples of individuals in Mali (West Africa). Blood samples from COVID-19 patients (n = 266) at Bamako Dermatology Hospital (HDB) and pre-COVID-19 donors (n = 283) from a previous malaria survey conducted in Dangassa village were tested by ELISA to assess IgG antibodies specific to the full-length spike (S) protein, the receptor-binding domain (RBD), and the receptor-binding motif (RBM436–507). Study participants were categorized by age, gender, treatment duration for COVID-19, and comorbidities. In addition, the cross-seroreactivity of samples from pre-COVID-19, malaria-positive patients against the three antigens was assessed. Recognition of the SARS-CoV-2 proteins by sera from COVID-19 patients was 80.5% for S, 71.1% for RBD, and 31.9% for RBM (p < 0.001). While antibody responses to S and RBD tended to be age-dependent, responses to RBM were not. Responses were not gender-dependent for any of the antigens. Higher antibody levels to S, RBD, and RBM at hospital entry were associated with shorter treatment durations, particularly for RBD (p < 0.01). In contrast, higher body weights negatively influenced the anti-S antibody response, and asthma and diabetes weakened the anti-RBM antibody responses. Although lower, a significant cross-reactive antibody response to S (21.9%), RBD (6.7%), and RBM (8.8%) was detected in the pre-COVID-19 and malaria samples. Cross-reactive antibody responses to RBM were mostly associated (p < 0.01) with the absence of current Plasmodium falciparum infection, warranting further study.
History
References
- https://doi.org//10.1007/978-1-4939-2438-7_1
- https://doi.org//10.1038/nm1143
- https://doi.org//10.1056/NEJMoa1211721
- https://doi.org//10.1038/s41564-020-0695-z
- https://doi.org//10.1016/j.jare.2020.03.005
- https://doi.org//10.1038/s41586-020-2918-0
- https://doi.org//10.1093/infdis/jit393
- https://doi.org//10.1038/s41586-020-2521-4
- https://doi.org//10.1038/s41591-020-0822-7
- https://doi.org//10.1056/NEJMoa2001017
- https://doi.org//10.1186/s12961-020-00623-8
- https://doi.org//10.3390/v12111251
- https://doi.org//10.1186/s41182-020-00228-5
- https://doi.org//10.1093/ckj/sfab048
- https://doi.org//10.1126/science.abc6952
- https://doi.org//10.1128/mBio.01991-20
- https://doi.org//10.1016/j.cell.2021.01.050
- https://doi.org//10.1016/j.tmaid.2020.101758
- https://doi.org//10.1186/s12936-020-03541-w
- https://doi.org//10.1016/j.nmni.2020.100817
- https://doi.org//10.1101/2021.05.10.21256855
- https://doi.org//10.3390/jcm9041138
- https://doi.org//10.1128/jcm.00514-21
- https://doi.org//10.3201/eid2701.203281
- https://doi.org//10.1101/2020.03.15.993097
- https://doi.org//10.1038/s41598-020-73491-5
- https://doi.org//10.1002/iid3.404
- https://doi.org//10.1126/scitranslmed.abc3103
- https://doi.org//10.1038/s41467-020-18450-4
- https://doi.org//10.1371/journal.pone.0241164
- https://doi.org//10.1038/s41591-020-0897-1
- https://doi.org//10.2807/1560-7917.Es.2020.25.16.2000421
- https://doi.org//10.1038/s41586-020-2912-6
- https://doi.org//10.15190/d.2020.17
- https://doi.org//10.1042/bj20040634
- https://doi.org//10.1186/s13054-017-1882-z
- https://doi.org//10.4269/ajtmh.20-0622
- https://doi.org//10.1126/science.abd7728
- https://doi.org//10.1038/s41392-021-00523-5
- https://doi.org//10.1128/mSphere.00802-20
- https://doi.org//10.3389/fimmu.2020.570018
- https://doi.org//10.1186/s12967-020-02392-y
- https://doi.org//10.1038/s41423-020-0400-4
- https://doi.org//10.1016/j.antiviral.2020.104820
- https://doi.org//10.1038/s41467-020-20654-7
- https://doi.org//10.1016/j.eng.2020.07.014
- https://doi.org//10.1038/s41594-020-0478-5
- https://doi.org//10.1093/nar/25.17.3389
- https://doi.org//10.1111/j.1742-4658.2005.04945.x
- https://doi.org//10.1016/S2666-5247(20)30098-7
- https://doi.org//10.1126/science.abe1107
- https://doi.org//10.1038/s41586-020-2180-5
- https://doi.org//10.2174/187153007782794371
- https://doi.org//10.1016/j.vaccine.2011.06.122
- https://doi.org//10.1093/cid/ciy514
- https://doi.org//10.1016/j.it.2020.03.007
- https://doi.org//10.3201/eid2607.200841
- https://doi.org//10.1111/resp.13852
- https://doi.org//10.1016/j.micinf.2020.05.008
- https://doi.org//10.1183/13993003.00763-2020
- https://doi.org//10.1093/jalm/jfaa079
- https://doi.org//10.1038/s41423-020-0474-z
- https://doi.org//10.3390/ijms21124446
- https://doi.org//10.1093/cid/ciaa310
- https://doi.org//10.1080/22221751.2020.1762515
- https://doi.org//10.1093/cid/ciaa461
- https://doi.org//10.1002/jmv.26937
- https://doi.org//10.3389/fphys.2020.571416
- https://doi.org//10.1016/j.arr.2020.101205
- https://doi.org//10.3389/fimmu.2020.02147
- https://doi.org//10.1186/s12879-021-06313-2
- https://doi.org//10.1371/journal.ppat.1008570
- https://doi.org//10.1016/j.metabol.2020.154262
- https://doi.org//10.1503/cmaj.200971
- https://doi.org//10.1038/s41586-020-2700-3
- https://doi.org//10.1002/jmv.25989
- https://doi.org//10.1002/jmv.25800
- https://doi.org//10.3389/fimmu.2020.01991
- https://doi.org//10.1183/13993003.00547-2020
- https://doi.org//10.1111/dom.14124
- https://doi.org//10.1002/dmrr.3377
- https://doi.org//10.1016/j.cell.2020.02.052
- https://doi.org//10.1016/0022-1759(85)90150-4
- https://doi.org//10.1016/j.jim.2005.11.008
- https://doi.org//10.1016/j.ijid.2020.12.067
- https://doi.org//10.1002/jmv.26628
- https://doi.org//10.1074/mcp.r200007-mcp200
- https://doi.org//10.1007/s00726-004-0141-1
- https://doi.org//10.1021/ac0513966
- https://doi.org//10.1002/eji.1830120803
- https://doi.org//10.1016/j.coi.2007.04.002
- https://doi.org//10.1016/j.bsheal.2021.04.001
- https://doi.org//10.1155/2020/8829848
- https://doi.org//10.1016/j.idcr.2020.e00879
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity